Novavax expects Phase 4 Covid trial to cost up to $90Mnews2025-08-06T18:05:52+00:00August 6th, 2025|Endpoints News|
AstraZeneca culls plans for Evusheld successor in the US following Covid evolutionnews2025-08-06T01:29:00+00:00August 6th, 2025|Endpoints News|
Prasad overrode FDA vaccine reviewers on Moderna’s Covid shot for young kidsnews2025-07-15T17:50:27+00:00July 15th, 2025|Endpoints News|
Trump axes Moderna bird flu pact worth more than $750Mnews2025-05-28T22:01:41+00:00May 28th, 2025|Endpoints News|
FDA vaccine advisors update Covid strain guidance following new frameworknews2025-05-22T19:55:09+00:00May 22nd, 2025|Endpoints News|
Future Covid vaccine approvals may narrow to older adults, high-risk peoplenews2025-05-20T15:00:27+00:00May 20th, 2025|Endpoints News|
HHS launches $500M universal vaccine platform as RFK Jr. shakes up US vaccine policynews2025-05-01T20:01:49+00:00May 1st, 2025|Endpoints News|
Vaxart says stop-work order was lifted on next-gen Covid vaccine news2025-04-28T18:43:51+00:00April 28th, 2025|Endpoints News|
Novavax responds to FDA’s request for new Covid vaccine trialnews2025-04-28T17:48:21+00:00April 28th, 2025|Endpoints News|
FDA asks Novavax for post-marketing data of its Covid vaccine, delaying approvalnews2025-04-23T12:06:09+00:00April 23rd, 2025|Endpoints News|
